Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001104659-16-129039

Options or other derivatives

  • CCO, GC and Corp. Sec. acquired 28,760 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Abraham David · CCO, GC and Corp. Sec.

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-06-21 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +28,760 $14.00 2026-06-20 28,760 28,760 D
Loading xslF345X03/a4.xml…